Optimized Rehabilitation After Anterior Cruciate Ligament Before Returning to Sport
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE SAINT ETIENNE · Apr 5, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve rehabilitation after surgery for a knee ligament injury, specifically focusing on the anterior cruciate ligament (ACL). After ACL reconstruction, patients typically follow a standard rehabilitation program for the first three months. This study aims to see if a personalized rehabilitation plan that includes monthly check-ups with physiotherapists from the third to the sixth month can help patients recover more effectively and reduce the risk of re-injury when they return to competitive sports.
To participate in this trial, individuals need to be between 65 and 91 years old, have had ACL surgery, and be involved in competitive sports that require quick movements, like soccer or basketball. Participants should be eager to return to their sport and must agree to the study by signing a consent form. Throughout the trial, participants will receive tailored rehabilitation support and guidance to help them safely get back to sports. This study is actively recruiting participants, and it’s important to note that some individuals may not be eligible due to specific health conditions or other factors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Affiliation to the French Social Security system
- • Patient who has had an ACL reconstruction regardless of the standard surgical technique used
- • Patient with a sports activity, pivot and/or contact (e.g. soccer, basketball, handball, rugby, judo...) and practiced in competition (Tegner sports activity scores \>7 and Marx scores \>11 before the accident.
- • Patient wishing to return to competitive sport
- • Consent signed by the patient
- Exclusion Criteria:
- • Contralateral or bilateral involvement or operated on for a re-injury of the ACL
- • Patients with a medical contraindication to the performance of one of the tests
- • Patients suffering from a neurological (motor and/or sensitive), vestibular or rheumatic pathology
- • Patient performing rehabilitation with a physiotherapist who does not wish to participate in the study.
- • Pregnant or breastfeeding woman
- • Patient under guardianship or curators
About Centre Hospitalier Universitaire De Saint Etienne
The Centre Hospitalier Universitaire (CHU) de Saint-Étienne is a leading academic medical center in France, dedicated to advancing healthcare through innovative clinical research and high-quality patient care. With a robust infrastructure that supports a wide range of medical specialties, CHU de Saint-Étienne fosters collaboration between healthcare professionals, researchers, and academic institutions. The center is committed to conducting rigorous clinical trials that adhere to ethical standards and regulatory requirements, aiming to improve treatment outcomes and enhance the overall health of the community. Through its dedication to scientific excellence and patient-centered care, CHU de Saint-Étienne plays a pivotal role in the advancement of medical knowledge and the development of new therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lyon, , France
Lyon, , France
Saint étienne, , France
Challes Les Eaux, , France
Firminy, , France
Geneve, , Switzerland
Domont, , France
Patients applied
Trial Officials
Thomas NERI, MD
Study Chair
CHU DE SAINT-ETIENNE
Grégory MOREL, Physio
Principal Investigator
CHU DE SAINT-ETIENNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials